<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260201068721N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-06-12</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the immediate and short-term effectiveness of adding the muscle energy technique to dry needling on pain and function in amateur bodybuilders with chronic non-specific low back pain</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the immediate and short-term effectiveness of adding the muscle energy technique to dry needling on pain and function in amateur bodybuilders with chronic non-specific low back pain</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-05-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/88923</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: To determine the treatment group of the individuals, first, the questionnaire is duplicated according to the number of participants.                                              Code 1 is written on them for the dry needling group and code 2 for the combination therapy group and the sheets are mixed together.                             The examiner randomly selects one of these sheets for each patient, Blinding description: In addition to this treatment, individuals in the dry needling group will undergo placebo MET treatment (position and method of treatment are the same as real MET treatment but without isometric contraction) for the target muscle. The evaluator and the therapist are different individuals, and the evaluator is unaware of the type of treatment received.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Low Back Pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Dry needling with muscle energy technique group. For the erector spinae muscles, a total of 10 needles are inserted bilaterally, 25 mm to the left and right of the spinous processes, and remain in the area for 10 minutes. For the quadratus lumborum muscles, a needle is inserted laterally from the L4 vertebra directly downwards in the direction of the transverse process of the vertebra and remains in the area for 10 minutes. Muscle energy technique treatment for these muscles is also a 10-second resistive contraction of the muscle in the opposite direction of the therapist's pressure with 20-35% of the maximum voluntary contraction, followed by 30 seconds of stretching with 3 repetitions for each muscle. The number of treatment sessions is one session. Intervention 2: Control group: Dry needling with  sham muscle energy technique group. IN the control group, all treatments will be performed similarly to the intervention group, with the difference that the muscle energy technique in this group will be performed as a placebo or unreal method, meaning without voluntary muscle contraction.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is I haven't consulted with the professors and haven't made a decision yet.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Morteza Mahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 57 , Somayie Ave , Ferdowsi Square , Tehran Town</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1581749811</zip>
        <telephone>+98 921 200 5384</telephone>
        <email>Mortezamahi61@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr sophia Naghdi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation , Safi Alishah St , Shemiran Intersection , Enghelab St, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1148965111</zip>
        <telephone>+98 912 297 9310</telephone>
        <email>naghdi@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Male bodybuilders with at least 6 months of training experience and at least 2 training sessions per week
Age range between  18-45 years old
Having back pain without a specific cause or pathology for at least three months or more 
Being able to read and write in Persian
Pain intensity between 3 and 7 based on VAS</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>45 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>People whose back pain is caused by a specific cause such as radiculopathy, tumor, vertebral fracture, or any other specific cause.
History of back and hip surgery
Having systemic diseases such as arthritis or tuberculosis
Needle phobia
Receiving other back treatments at the same time</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Low back pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Dry needling with muscle energy technique group. For the erector spinae muscles, a total of 10 needles are inserted bilaterally, 25 mm to the left and right of the spinous processes, and remain in the area for 10 minutes. For the quadratus lumborum muscles, a needle is inserted laterally from the L4 vertebra directly downwards in the direction of the transverse process of the vertebra and remains in the area for 10 minutes. Muscle energy technique treatment for these muscles is also a 10-second resistive contraction of the muscle in the opposite direction of the therapist's pressure with 20-35% of the maximum voluntary contraction, followed by 30 seconds of stretching with 3 repetitions for each muscle. The number of treatment sessions is one session.</i_keyword>
      <i_keyword>Control group: Dry needling with  sham muscle energy technique group. IN the control group, all treatments will be performed similarly to the intervention group, with the difference that the muscle energy technique in this group will be performed as a placebo or unreal method, meaning without voluntary muscle contraction.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: Before the intervention, immediately after the intervention, and one week after the intervention. Method of measurement: by using visual analog scale.</prim_outcome>
      <prim_outcome>Function. Timepoint: Before the intervention, immediately after the intervention, and one week after the intervention. Method of measurement: by using functional rating index.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Back Muscles Endurance. Timepoint: Before the intervention, immediately after the intervention, and one week after the intervention. Method of measurement: By Sorensen Test.</sec_outcome>
      <sec_outcome>Lumbar Flexion Range Of Motion. Timepoint: Before the intervention, immediately after the intervention, and one week after the intervention. Method of measurement: The distance between two specific points on the lumbar spine in flexion and extension is measured and recorded.</sec_outcome>
      <sec_outcome>Lumbar Side Flexion Range Of Motion. Timepoint: Before the intervention, immediately after the intervention, and one week after the intervention. Method of measurement: By goniometer.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-02-23</approval_date>
        <contact_name>Ethics committee of School  of Nursing and Rehabilitation Of Tehran University of Medical Sciences</contact_name>
        <contact_address>Next to Imam Khomeini Hospital, Dr. Gharib Intersection, Nosrat Street Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
